RA Capital Management’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-3,115,008
| Closed | -$61.3M | – | 103 |
|
|
2021
Q4 | $61.3M | Hold |
3,115,008
| – | – | 1.08% | 27 |
|
|
2021
Q3 | $100M | Hold |
3,115,008
| – | – | 1.39% | 23 |
|
|
2021
Q2 | $105M | Hold |
3,115,008
| – | – | 1.69% | 16 |
|
|
2021
Q1 | $117M | Sell |
3,115,008
-710,000
| -19% | -$26.7M | 1.76% | 14 |
|
|
2020
Q4 | $127M | Hold |
3,825,008
| – | – | 1.78% | 13 |
|
|
2020
Q3 | $140M | Hold |
3,825,008
| – | – | 2.57% | 8 |
|
|
2020
Q2 | $126M | Buy |
3,825,008
+117,600
| +3% | +$3.87M | 2.45% | 12 |
|
|
2020
Q1 | $95.7M | Buy |
3,707,408
+60,600
| +2% | +$1.56M | 3.02% | 11 |
|
|
2019
Q4 | $114M | Buy |
+3,646,808
| New | +$114M | 3.44% | 9 |
|